BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 18948228)

  • 1. Staging of pancreatic adenocarcinoma by imaging studies.
    Wong JC; Lu DS
    Clin Gastroenterol Hepatol; 2008 Dec; 6(12):1301-8. PubMed ID: 18948228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based imaging of pancreatic malignancies.
    Kinney T
    Surg Clin North Am; 2010 Apr; 90(2):235-49. PubMed ID: 20362784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodality staging optimizes resectability in patients with pancreatic and ampullary cancer.
    Awad SS; Colletti L; Mulholland M; Knol J; Rothman ED; Scheiman J; Eckhauser FE
    Am Surg; 1997 Jul; 63(7):634-8. PubMed ID: 9202539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography.
    Ergul N; Gundogan C; Tozlu M; Toprak H; Kadıoglu H; Aydin M; Cermik TF
    Rev Esp Med Nucl Imagen Mol; 2014; 33(3):159-64. PubMed ID: 24140024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma.
    Mertz HR; Sechopoulos P; Delbeke D; Leach SD
    Gastrointest Endosc; 2000 Sep; 52(3):367-71. PubMed ID: 10968852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of pancreatic adenocarcinoma: update on staging/resectability.
    Tamm EP; Balachandran A; Bhosale PR; Katz MH; Fleming JB; Lee JH; Varadhachary GR
    Radiol Clin North Am; 2012 May; 50(3):407-28. PubMed ID: 22560689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison between spiral x-ray computed tomography and endosonography in the diagnosis and staging of adenocarcinoma of the pancreas. Clinical preliminary study].
    Dufour B; Zins M; Vilgrain V; Levy P; Bernades P; Menu Y
    Gastroenterol Clin Biol; 1997; 21(2):124-30. PubMed ID: 9161478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of endoscopic ultrasound and magnetic resonance imaging in the preoperative staging of pancreatic adenocarcinoma.
    Ahmad NA; Lewis JD; Siegelman ES; Rosato EF; Ginsberg GG; Kochman ML
    Am J Gastroenterol; 2000 Aug; 95(8):1926-31. PubMed ID: 10950037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness.
    Heinrich S; Goerres GW; Schäfer M; Sagmeister M; Bauerfeind P; Pestalozzi BC; Hany TF; von Schulthess GK; Clavien PA
    Ann Surg; 2005 Aug; 242(2):235-43. PubMed ID: 16041214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of (18)fluoro-deoxyglucose positron emission tomography/computed tomography in resectable pancreatic cancer.
    Crippa S; Salgarello M; Laiti S; Partelli S; Castelli P; Spinelli AE; Tamburrino D; Zamboni G; Falconi M
    Dig Liver Dis; 2014 Aug; 46(8):744-9. PubMed ID: 24721105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer.
    Strobel K; Heinrich S; Bhure U; Soyka J; Veit-Haibach P; Pestalozzi BC; Clavien PA; Hany TF
    J Nucl Med; 2008 Sep; 49(9):1408-13. PubMed ID: 18703604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging Tests for the Diagnosis and Staging of Pancreatic Adenocarcinoma: A Meta-Analysis.
    Treadwell JR; Zafar HM; Mitchell MD; Tipton K; Teitelbaum U; Jue J
    Pancreas; 2016 Jul; 45(6):789-95. PubMed ID: 26745859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic tumors: role of imaging in the diagnosis, staging, and treatment.
    Delbeke D; Pinson CW
    J Hepatobiliary Pancreat Surg; 2004; 11(1):4-10. PubMed ID: 15747028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms.
    Farma JM; Santillan AA; Melis M; Walters J; Belinc D; Chen DT; Eikman EA; Malafa M
    Ann Surg Oncol; 2008 Sep; 15(9):2465-71. PubMed ID: 18551347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multi-detector row CT.
    Fletcher JG; Wiersema MJ; Farrell MA; Fidler JL; Burgart LJ; Koyama T; Johnson CD; Stephens DH; Ward EM; Harmsen WS
    Radiology; 2003 Oct; 229(1):81-90. PubMed ID: 14519871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative assessment of pancreatic tumors using magnetic resonance imaging, endoscopic ultrasonography, positron emission tomography and laparoscopy.
    Borbath I; Van Beers BE; Lonneux M; Schoonbroodt D; Geubel A; Gigot JF; Deprez PH
    Pancreatology; 2005; 5(6):553-61. PubMed ID: 16113592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact on clinical practice of endoscopic ultrasonography used for the diagnosis and staging of pancreatic adenocarcinoma.
    Queneau PE; Sauvé G; Koch S; Thibault P; Cléau D; Heyd B; Mantion G; Carayon P
    JOP; 2001 May; 2(3):98-104. PubMed ID: 11870331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
    Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of EUS-FNA in patients suspected of having pancreatic cancer with a focal lesion on CT scan/MRI but without obstructive jaundice.
    Krishna NB; LaBundy JL; Saripalli S; Safdar R; Agarwal B
    Pancreas; 2009 Aug; 38(6):625-30. PubMed ID: 19506529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.